Gut microbiota modulation of chemotherapy efficacy and toxicity.
about
The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.Human microbiome signatures of differential colorectal cancer drug metabolism.Highlights from the Inaugural International Cancer Microbiome Consortium Meeting (ICMC), 5-6 September 2017, London, UK.Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients.Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy.The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review.Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.Microbiota transplantation: concept, methodology and strategy for its modernization.Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.Pharmacomicrobiomics: a novel route towards personalized medicine?Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.Gut microbiome modulates efficacy of immune checkpoint inhibitors.Role of the gut microbiota in nutrition and health.Moving on from Metchnikoff: thinking about microbiome therapeutics in cancerGrow With the Challenge - Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer TherapyGut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatmentThe implementation of omics technologies in cancer microbiome research
P2860
Q38369889-94BE06BB-04CC-443E-ACA3-7021B1381937Q42958061-B2638BE2-086A-4719-BDCF-3500DD804CD4Q47100145-FB4143B3-ED04-4FD8-9036-D037EB7726E6Q47118060-80A36646-E70D-4406-88A7-7B5F4A741560Q47159439-50B4B85D-5DC0-4B41-B933-088D7A251CC9Q47230140-2E4DD0FC-FC5A-4193-84FD-49847B0B63FBQ47425267-CB136138-A49C-4EBF-8E8E-5640F9127FDFQ49787893-BDBBA2A8-0468-4A7E-AF26-8A4986EEC74BQ50067815-F070D5D5-201D-4A64-B299-FC55FE26CAE1Q52716963-D254581F-0123-42DE-8CE6-29AE4619FFE1Q53688957-80C24BFA-F838-4911-A51B-BC3AD7E8E527Q55007103-3B3D6346-6B05-43D2-98A3-CCC3F8C4C10FQ55040688-4B9FE222-FBA0-449C-BB50-58966438CC2BQ55240704-AB48AAC2-CFF1-4BB5-A66E-93717D56DCA5Q55383691-EEE0DAB5-608F-4AC8-8046-7DF6611501A2Q57160565-807624CE-99B7-48A4-969E-69A5D979D5D2Q57191774-9ECF9640-D1B2-46C8-86FE-CD6C26C61F37Q58762645-26647DD1-232E-4CC1-B63C-379F6B94F4C0Q58762649-93819553-75EF-460E-92BD-CB75F7DB3077
P2860
Gut microbiota modulation of chemotherapy efficacy and toxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@ast
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@en
type
label
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@ast
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@en
prefLabel
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@ast
Gut microbiota modulation of chemotherapy efficacy and toxicity.
@en
P2093
P2860
P50
P356
P1476
Gut microbiota modulation of chemotherapy efficacy and toxicity
@en
P2093
Ian D Wilson
James L Alexander
Jeremy K Nicholson
P2860
P2888
P304
P356
10.1038/NRGASTRO.2017.20
P407
P577
2017-03-08T00:00:00Z